Annual ROE
-12.27%
-26.30%-187.46%
December 31, 2023
Summary
- As of February 12, 2025, ABCL annual return on equity is -12.27%, with the most recent change of -26.30% (-187.46%) on December 31, 2023.
- During the last 3 years, ABCL annual ROE has fallen by -40.56% (-143.37%).
- ABCL annual ROE is now -143.37% below its all-time high of 28.29%, reached on December 31, 2020.
Performance
ABCL ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-15.55%
-2.27%-17.09%
September 30, 2024
Summary
- As of February 12, 2025, ABCL quarterly return on equity is -15.55%, with the most recent change of -2.27% (-17.09%) on September 30, 2024.
- Over the past year, ABCL quarterly ROE has dropped by -2.27% (-17.09%).
- ABCL quarterly ROE is now -130.79% below its all-time high of 50.50%, reached on March 31, 2021.
Performance
ABCL Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
ABCL ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -187.5% | -17.1% |
| 3 y3 years | -143.4% | -156.1% |
| 5 y5 years | -561.3% | +2.9% |
ABCL ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -174.2% | at low | -170.8% | at low |
| 5 y | 5-year | -143.4% | +39.4% | -130.8% | +57.3% |
| alltime | all time | -143.4% | +39.4% | -130.8% | +57.3% |
AbCellera Biologics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -15.55%(+17.1%) |
| Jun 2024 | - | -13.28%(+6.1%) |
| Mar 2024 | - | -12.52%(+2.1%) |
| Dec 2023 | -12.27%(-187.5%) | -12.26%(+15.2%) |
| Sep 2023 | - | -10.64%(+75.6%) |
| Jun 2023 | - | -6.06%(+47.8%) |
| Mar 2023 | - | -4.10%(-130.7%) |
| Dec 2022 | 14.03% | 13.37%(-39.2%) |
| Sep 2022 | - | 21.98%(+17.7%) |
| Jun 2022 | - | 18.67%(-6.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | 20.04%(+23.6%) |
| Dec 2021 | 16.53%(-41.6%) | 16.21%(-41.5%) |
| Sep 2021 | - | 27.71%(-31.0%) |
| Jun 2021 | - | 40.14%(-20.5%) |
| Mar 2021 | - | 50.50%(+31.6%) |
| Dec 2020 | 28.29%(-239.8%) | 38.36%(+6874.5%) |
| Sep 2020 | - | 0.55%(-98.1%) |
| Jun 2020 | - | 28.96%(-179.5%) |
| Mar 2020 | - | -36.43%(+127.5%) |
| Dec 2019 | -20.23%(-860.5%) | -16.01% |
| Dec 2018 | 2.66% | - |
FAQ
- What is AbCellera Biologics annual return on equity?
- What is the all time high annual ROE for AbCellera Biologics?
- What is AbCellera Biologics annual ROE year-on-year change?
- What is AbCellera Biologics quarterly return on equity?
- What is the all time high quarterly ROE for AbCellera Biologics?
- What is AbCellera Biologics quarterly ROE year-on-year change?
What is AbCellera Biologics annual return on equity?
The current annual ROE of ABCL is -12.27%
What is the all time high annual ROE for AbCellera Biologics?
AbCellera Biologics all-time high annual return on equity is 28.29%
What is AbCellera Biologics annual ROE year-on-year change?
Over the past year, ABCL annual return on equity has changed by -26.30% (-187.46%)
What is AbCellera Biologics quarterly return on equity?
The current quarterly ROE of ABCL is -15.55%
What is the all time high quarterly ROE for AbCellera Biologics?
AbCellera Biologics all-time high quarterly return on equity is 50.50%
What is AbCellera Biologics quarterly ROE year-on-year change?
Over the past year, ABCL quarterly return on equity has changed by -2.27% (-17.09%)